Vallières Cindy, Alexander Cameron, Avery Simon V
School of Life Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Appl Microbiol Biotechnol. 2021 Apr;105(7):2867-2875. doi: 10.1007/s00253-021-11211-3. Epub 2021 Mar 18.
Fungi cause diverse, serious socio-economic problems, including biodeterioration of valuable products and materials that spawns a biocides industry worth ~$11 billion globally. To help combat environmental fungi that commonly colonise material products, this study tested the hypothesis that combination of an approved fungicide with diverse agents approved by the FDA (Food and Drug Administration) could reveal potent combinatorial activities with promise for fungicidal applications. The strategy to use approved compounds lowers potential development risks for any effective combinations. A high-throughput assay of 1280 FDA-approved compounds was conducted to find those that potentiate the effect of iodopropynyl-butyl-carbamate (IPBC) on the growth of Trichoderma virens; IPBC is one of the two most widely used Biocidal Products Regulations-approved fungicides. From this library, 34 compounds in combination with IPBC strongly inhibited fungal growth. Low-cost compounds that gave the most effective growth inhibition were tested against other environmental fungi that are standard biomarkers for resistance of synthetic materials to fungal colonisation. Trifluoperazine (TFZ) in combination with IPBC enhanced growth inhibition of three of the five test fungi. The antifungal hexetidine (HEX) potentiated IPBC action against two of the test organisms. Testable hypotheses on the mechanisms of these combinatorial actions are discussed. Neither IPBC + TFZ nor IPBC + HEX exhibited a combinatorial effect against mammalian cells. These combinations retained strong fungal growth inhibition properties after incorporation to a polymer matrix (alginate) with potential for fungicide delivery. The study reveals the potential of such approved compounds for novel combinatorial applications in the control of fungal environmental opportunists. KEY POINTS: • Search with an approved fungicide to find new fungicidal synergies in drug libraries. • New combinations inhibit growth of key environmental fungi on different matrices. • The approach enables a more rapid response to demand for new biocides.
真菌会引发各种严重的社会经济问题,包括使贵重产品和材料发生生物劣化,这催生了一个全球价值约110亿美元的杀生物剂产业。为了帮助对抗通常会在材料产品上定殖的环境真菌,本研究检验了这样一个假设:一种已获批准的杀真菌剂与美国食品药品监督管理局(FDA)批准的多种药剂相结合,可能会展现出具有杀真菌应用前景的强大组合活性。使用已获批准化合物的策略降低了任何有效组合的潜在开发风险。对1280种FDA批准的化合物进行了高通量检测,以找出那些能增强碘丙炔醇丁基氨甲酸酯(IPBC)对绿色木霉生长抑制作用的化合物;IPBC是两种使用最广泛的经《杀生物剂产品法规》批准的杀真菌剂之一。从这个库中,34种与IPBC组合的化合物强烈抑制了真菌生长。对产生最有效生长抑制作用的低成本化合物针对其他环境真菌进行了测试,这些真菌是合成材料抗真菌定殖的标准生物标志物。三氟拉嗪(TFZ)与IPBC组合增强了对五种测试真菌中三种的生长抑制作用。抗真菌剂己脒定(HEX)增强了IPBC对两种测试生物体的作用。讨论了关于这些组合作用机制的可检验假设。IPBC + TFZ和IPBC + HEX对哺乳动物细胞均未表现出组合效应。将这些组合掺入具有杀真菌剂递送潜力的聚合物基质(藻酸盐)后,仍保留了强大的真菌生长抑制特性。该研究揭示了此类已获批准化合物在控制真菌环境机会致病菌方面进行新型组合应用的潜力。要点:• 用一种已获批准的杀真菌剂进行筛选,以在药物库中找到新的杀真菌协同作用。• 新组合抑制关键环境真菌在不同基质上的生长。• 该方法能够更快地响应新型杀生物剂的需求。